-
Optimizing EAE Models: Applied Workflows with MOG (35-55) Pe
2026-07-08
MOG (35-55) Peptide enables robust, reproducible induction of experimental autoimmune encephalomyelitis (EAE), the gold-standard model for multiple sclerosis research. This guide delivers protocol enhancements, troubleshooting strategies, and data-driven insights to elevate neuroinflammation assays and autoimmune disease modeling.
-
EZ Cap™ Human PTEN mRNA (ψUTP): Translational Impact and Pro
2026-07-08
Explore the advanced features of EZ Cap™ Human PTEN mRNA (ψUTP) and their practical implications for cancer research. This article uniquely analyzes translational applications, protocol design, and nanoparticle-mediated delivery strategies for in vitro transcribed mRNA.
-
High-Throughput Mapping of SARS-CoV-2 Spike–ACE2 Compatibili
2026-07-07
Shukla et al. introduce a multiplexed, barcoded infection assay to systematically analyze how SARS-CoV-2 spike variants interact with diverse ACE2 orthologs and mutants. Their findings reveal that viral spike mutations drive complex shifts in host receptor compatibility, clarifying mechanisms of cross-species transmission and viral adaptation.
-
Nirmatrelvir (PF-07321332) in SARS-CoV-2 Research Workflows
2026-07-07
Nirmatrelvir (PF-07321332) sets a benchmark for selective SARS-CoV-2 replication inhibition, enabling robust, reproducible assays in antiviral therapeutics research. This guide translates recent mechanistic discoveries and workflow advances into actionable experimental strategies for coronavirus infection studies.
-
Strategic Deployment of EZ Cap™ Mouse IL-12 mRNA (m1Ψ) in Ne
2026-07-06
Explore how EZ Cap™ Mouse IL-12 mRNA (m1Ψ) enables precise, stable cytokine expression for advanced immunotherapy research. This article uniquely analyzes delivery innovation and practical assay design, setting it apart from prior reviews.
-
USP7 Drives Macrophage Polarization via PKM2 in Pancreatitis
2026-07-06
This study uncovers how ubiquitin-specific protease 7 (USP7) promotes pro-inflammatory macrophage polarization in severe acute pancreatitis by regulating pyruvate kinase M2 (PKM2)-dependent metabolic reprogramming. These findings highlight a mechanistic link between immune cell metabolism and inflammation, offering new avenues for therapeutic intervention targeting the USP7–PKM2 axis.
-
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1
2026-07-05
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent designed for efficient activation of carboxyl groups in peptide synthesis, bioconjugation, and nucleotide workflows. Its use is strictly limited to in vitro chemical applications, as there is no supporting data for in vivo or clinical contexts.
-
MOG (35-55) Peptide: Mechanistic Advances and Strategic Impa
2026-07-04
This thought-leadership article explores how the MOG (35-55) peptide is redefining experimental autoimmune encephalomyelitis and multiple sclerosis research. By synthesizing recent mechanistic discoveries—including PARP7-STAT1/STAT2 regulation—and benchmarking APExBIO’s peptide, we provide translational researchers with actionable guidance for model optimization, workflow reproducibility, and strategic foresight. This piece goes beyond standard product overviews, bridging biological rationale, experimental protocols, and the evolving clinical landscape.
-
S Tag Peptide: Protocols for Solubility and Protein Detectio
2026-07-03
S Tag Peptide (SKU A6007) is a 15-amino acid fusion tag designed to enhance protein solubility and enable efficient detection or affinity purification via anti-S-Tag antibodies. It is best suited for aqueous recombinant protein workflows and not recommended for applications requiring ethanol solubility or standalone enzymatic activity.
-
Synergistic PI3K–AKT–ERK Blockade Overcomes Gefitinib Resist
2026-07-03
This study presents a rationally engineered nanoplatform for co-delivery of gefitinib and crizotinib, enabling dual blockade of the PI3K–AKT–ERK axis to overcome drug resistance and metastasis in lung adenocarcinoma. The integrated approach demonstrates robust efficacy in preclinical models, providing a clinically relevant strategy for EGFR-TKI refractory tumors.
-
AngII-Induced M1 Macrophage Polarization via Cx43/NF-κB Path
2026-07-02
This study elucidates how angiotensin II drives pro-inflammatory M1 macrophage polarization through the connexin 43 (Cx43)/NF-κB (p65) signaling axis. The findings provide mechanistic clarity for researchers investigating immune modulation and highlight the use of selective Cx43 hemichannel blockers as a tool for dissecting inflammatory pathways.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Advanced Strategies
2026-07-02
Explore how the Cy3 Goat Anti-Rabbit IgG (H+L) Antibody enhances neuroinflammation and gut–brain axis research through superior signal amplification and specificity. This in-depth analysis reveals protocol optimizations and assay decisions inspired by recent advances in depression models.
-
CXCR4-Targeted Theranostics in Lymphoma: Imaging and Precisi
2026-07-01
This review highlights recent advances in CXCR4-targeted imaging and therapeutic agents for lymphoma, emphasizing their integration into precision oncology. The findings demonstrate that leveraging CXCR4 overexpression enables both enhanced diagnostic accuracy and new avenues for targeted intervention in aggressive hematologic malignancies.
-
V5 Epitope Tag Peptide: Precision Tag for Protein Detection
2026-07-01
The V5 Epitope Tag Peptide (GKPIPNPLLGLDST peptide) enables high-specificity tagging of recombinant proteins for Western blotting, immunoprecipitation, and advanced imaging. Its robust solubility and validated antibody recognition facilitate reproducible and efficient protein detection across molecular biology workflows.
-
1-myristoylglycerophosphocholine for Lipid Signaling & Fibro
2026-06-30
1-myristoylglycerophosphocholine (14:0 Lyso-PC) empowers researchers to dissect lipid-driven signaling in smooth muscle and fibrosis models with superior solubility and reproducibility. Recent mechanistic advances reveal its pivotal role in fibroblast activation, offering new experimental leverage in disease modeling and pathway analysis.